A study by scientists at the Emory Vaccine Center, in collaboration with the biotechnology company Atreca, Inc., has found that antibodies generated from the blood of survivors of Ebola virus disease can strongly neutralize ...
Oct 26, 2016
0
0
India suffers from the highest number of dengue infections in the world, but there are few studies, if any, to understand the immune cells involved in fighting the virus.
Oct 20, 2016
0
0
Emergency health facilities could be the key to survival for Ebola patients, an international study involving University of Queensland researchers has found.
Oct 17, 2016
0
1
Initial data from a Liberian public health program show about 9 percent (38) of 429 male Ebola survivors had fragments of Ebola virus in their semen. Of those, 63 percent had semen samples that tested positive for Ebola fragments ...
Aug 31, 2016
0
0
People infected with Ebola virus were 20 percent more likely to survive if they were co-infected with malaria-causing Plasmodium parasites, according to data collected at an Ebola diagnostic laboratory in Liberia in 2014-15. ...
Aug 16, 2016
0
8
A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today.
Jul 19, 2016
0
1
Though the West African Ebola outbreak that began in 2013 is now under control, 23 countries remain environmentally suitable for animal-to-human transmission of the Ebola virus. Only seven of these countries have experienced ...
Jul 14, 2016
1
0
A first-of-its-kind Ebola study yields clues to how some people are able to survive the deadly virus and suggests possible avenues for treatments that could save more lives.
Jun 30, 2016
0
0
(HealthDay)—Infection control measures have been developed to strengthen hospitals' capacity for safely diagnosing and treating patients with Ebola virus disease (EVD), according to a review published online May 10 in the ...
May 13, 2016
0
1
In a study appearing in the April 19, 2016 issue of JAMA, Matthew D. Snape, F.R.C.P.C.H., M.D., of the University of Oxford, United Kingdom, and colleagues conducted a phase 1 trial to evaluate the tolerability and immunogenicity ...
Apr 19, 2016
0
4
